PureHealth Holding PJSC, the largest healthcare group in the Middle East, has announced strong financial results for the first quarter of 2025, reporting a net profit of AED 505 million and an EBITDA of AED 1.1 billion. The Group’s revenue reached AED 6.6 billion for the quarter, reflecting an 8% year-on-year increase powered by growth across all major segments.
These results underline the strength of PureHealth’s integrated healthcare model and its long-term strategy to transform healthcare delivery across the UAE and globally.
Strong Performance Across All Segments
The Group’s hospital network remained the largest contributor, accounting for 59% of overall revenue. The Hospital segment generated AED 5.0 billion, driven by sustained growth in patient volumes across both UAE and UK assets. Over 2.5 million patient interactions were recorded during the quarter, with outpatient volumes rising 9% year-on-year and inpatient visits increasing by 4%.
PureHealth’s Insurance segment also saw significant growth, generating AED 1.86 billion in revenue, up 19% year-on-year. High renewal rates and entry into new markets contributed to a 15% increase in Gross Written Premiums. Notably, the launch of new products, including “Amanak” for SMEs in the Northern Emirates, and a global partnership with AXA to offer International Private Medical Insurance, expanded the Group’s insurance footprint.
The Procurement segment brought in AED 1.2 billion in Q1 2025, an 11% increase year-on-year. This was supported by deeper partnerships with suppliers, an expanding customer base across the GCC, and a broader focus on advanced medical technologies and specialty pharmaceuticals.
Diagnostics also performed strongly, with revenues up 14% to AED 261 million. Testing volumes grew by 16%, boosted by the integration of Sheikh Shakhbout Medical City (SSMC) into the PureLab network, which added over 700,000 tests during the period.
The Technology Services segment saw standout growth of 132% year-on-year, reporting AED 152 million in revenue. This was led by PureCS, the Group’s dedicated healthtech company, which accelerated the deployment of clinical and operational technology solutions.
Major Strategic Developments
During the quarter, PureHealth announced a dividend of AED 343 million for FY 2024, its first since listing on the Abu Dhabi Securities Exchange (ADX), representing a 20% payout ratio.
In the UAE, PureHealth continued to enhance its healthcare delivery leadership. SEHA expanded mental health services, opened new clinics, and onboarded 150 new specialist physicians. SSMC strengthened its position in cardiac and specialty care, with a focus on women’s and adolescent mental health.
Internationally, the UK-based Circle Health Group secured the largest European order of surgical robots, enhanced oncology services with in-house monoclonal antibody preparation, and opened new outpatient centers in Cheshire, Inverness, and Glasgow.
The Daman insurance arm made headlines with the launch of “Amanak,” tailored for employees of small and medium enterprises, while also entering a strategic partnership with AXA for international coverage and expanding its facultative reinsurance offerings.
Also Read: Lead With Purpose: My First Advice – Rola Hammoud
PureLab, the Diagnostics vertical, launched the Abu Dhabi Public Health Centre Surveillance Lab, a facility specializing in molecular and genomic testing, and signed an MoU with ExpressMed Diagnostics & Research Bahrain to support regional expansion.
Rafed, the Group’s procurement entity, continued to support national healthcare priorities by managing the UAE’s Nationwide Immunisation Programme.
